Deutsch English Français

Contact

EP2487163

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2487163

EP2487163 - Modulators of pharmacokinetic properties of therapeutics [Right-click to bookmark this link]
Status	Patent revoked Status updated on 09.12.2022 Database last updated on 20.12.2024
Former	The patent has been granted Status updated on 22.11.2022
Most recent event Tooltip	09.12.2022	Revocation of patent	published on 11.01.2023 [2023/02]
Applicant(s)	For all designated states GILEAD SCIENCES, INC. 333 Lakeside Drive Foster City California 94404 / US
	[2012/33]
Inventor(s)	01 / Desai, Manoj, C. 1975 Mohawk Drive Pleasant Hill, CA California 94523 / US
	02 / Hong, Allen, Y. 446 S. Catalina Avenue, Apt. 203 Pasadena, CA California 91106 / US
	03 / Hui, Hon, C. 853 Woodside Way, 229 San Mateo, CA California 94401 / US
	04 / Liu, Hongtao 10320 Orange Avenue Cupertino, CA California 95014 / US
	05 / Vivian, Radall, W. 1430 Via Vista San Mateo, CA California 94404 / US
	06 / Xu, Lianhong 970 Blair Court Palo Alto, CA California 94303 / US
	[2012/33]
Representative(s)	Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
	[N/P]
Former [2014/27]	Hallybone, Huw George, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
Former [2012/33]	Reitstötter - Kinzebach Patentanwälte Sternwartstrasse 4 81679 München / DE
Application number, filing date	12167591.2	22.02.2008
	[2012/33]
Priority number, date	US20070903228P	23.02.2007 Original published format: US 903228 P
	US20070958716P	06.07.2007 Original published format: US 958716 P
	[2012/33]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	EP2487163
	Date:	15.08.2012
	Language:	EN
	[2012/33]
	Type:	B1 Patent specification
	No.:	EP2487163
	Date:	17.08.2016
	Language:	EN
	[2016/33]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	29.06.2012
Classification	IPC:	C07D277/28, C07D417/14, A61K31/427, A61P31/12	[2012/33]
	CPC:	C07D277/28 (EP); A61P31/00 (EP); A61P31/12 (EP); C07D417/14 (EP)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2016/33]
Former [2012/33]	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR
Extension states	AL	15.02.2013
	BA	15.02.2013
	MK	15.02.2013
	RS	15.02.2013
Title	German:	Modulatoren der pharmakokinetischen Eigenschaften von Therapeutika	[2012/33]
	English:	Modulators of pharmacokinetic properties of therapeutics	[2012/33]
	French:	Modulateurs de propriétés pharmacocinétiques d'agents thérapeutiques	[2012/33]
Examination procedure	15.02.2013	Examination requested [2013/13]
	26.03.2013	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
	05.06.2013	Amendment by applicant (claims and/or description)
	11.03.2015	Despatch of a communication from the examining division (Time limit: M06)
	10.09.2015	Reply to a communication from the examining division
	16.02.2016	Communication of intention to grant the patent
	13.04.2016	Observations by third parties
	17.06.2016	Fee for grant paid
	17.06.2016	Fee for publishing/printing paid
	17.06.2016	Receipt of the translation of the claim(s)
Parent application(s) Tooltip	EP08743531.9 / EP2118082
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20080743531) is 03.05.2010
Opposition(s)	Opponent(s)	01 16.05.2017 19.05.2017 ADMISSIBLE Teva Pharmaceutical Industries Ltd. 124 Dvora HaNevi'a St. 6944020 Tel Aviv / IL Opponent's representative Eder, Michael Df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Fünf Höfe Theatinerstrasse 16 80333 München / DE
		02 17.05.2017 30.05.2017 ADMISSIBLE Cooke, Richard Elkington and Fife LLP Patents Department 3-4 Holborn Circus London EC1N 2HA / GB Opponent's representative Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB
		[2021/47]
	Former [2018/52]
	Opponent(s)	01 16.05.2017 19.05.2017 ADMISSIBLE Teva Pharmaceutical Industries LTD. 5 Basel Street Petah Tiqva 49131 / IL Opponent's representative Eder, Michael Df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Fünf Höfe Theatinerstrasse 16 80333 München / DE
		02 17.05.2017 30.05.2017 ADMISSIBLE Cooke, Richard Elkington and Fife LLP Patents Department 3-4 Holborn Circus London EC1N 2HA / GB Opponent's representative Elkington & Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB
	Former [2017/25]
	Opponent(s)	01 16.05.2017 ADMISSIBLE Teva Pharmaceutical Industries LTD. 5 Basel Street Petah Tiqva 49131 / IL Opponent's representative Eder, Michael Df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Fünf Höfe Theatinerstrasse 16 80333 München / DE
		02 17.05.2017 Cooke, Richard Elkington and Fife LLP Patents Department 3-4 Holborn Circus London EC1N 2HA / GB
	21.06.2017	Invitation to proprietor to file observations on the notice of opposition
	19.12.2017	Reply of patent proprietor to notice(s) of opposition
	12.11.2018	Date of oral proceedings
	05.12.2018	Despatch of interlocutory decision in opposition
	05.12.2018	Despatch of minutes of oral proceedings
	05.07.2022	Legal effect of revocation of patent [2023/02]
	22.11.2022	Despatch of communication that the patent will be revoked
Appeal following opposition	13.02.2019	Appeal received No. T0358/19
	15.04.2019	Statement of grounds filed
	05.07.2022	Result of appeal procedure: revocation of the patent
	22.11.2022	Despatch of the decision of the Board of Appeal
	04.02.2019	Appeal received No. T0358/19
	12.04.2019	Statement of grounds filed
	05.07.2022	Result of appeal procedure: revocation of the patent
	22.11.2022	Despatch of the decision of the Board of Appeal
	05.07.2022	Date of oral proceedings
Request for further processing for:	The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
	05.06.2013	Request for further processing filed
	05.06.2013	Full payment received (date of receipt of payment) Request granted
	20.06.2013	Decision despatched
Fees paid	Renewal fee
	11.05.2012	Renewal fee patent year 03
	11.05.2012	Renewal fee patent year 04
	11.05.2012	Renewal fee patent year 05
	27.02.2013	Renewal fee patent year 06
	27.02.2014	Renewal fee patent year 07
	26.02.2015	Renewal fee patent year 08
	26.02.2016	Renewal fee patent year 09
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[A]EP1183026 ;
		[A]WO9701349 (ABBOTT LAB [US]);
		[XP]WO2008010921 (GILEAD SCIENCES INC [US], et al)
	by applicant	WO2008010921
	other	WO9701349
		EP1183026
	Opposition	WO9701349
		EP1183026
		WO0074677
		WO2008010921

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p